TY - BOOK AU - Zahida Qadir AU - Dr.H.A.Hashmi AU - Dr.Shakil Akhtar Khan ED - ED - Faculty of Veterinary Sciences TI - Study On Naturtal Quine Strongylosis And Its Control U1 - 0809,T PY - 2001/// KW - Department of Parasitology N1 - Two hundred equines of different age, sex and breed were subjected to coprological examination. A total of 65.51% sample were found to be infected with various helminths. Strongyles were the most common parasites and were detected in 58.5% of total faecal samples. The other species identified in this study included P. jprum (2%), Dictyocalus arnifeldi (1.5%), Gafitrodisus aegvuticus (1.5%), Anaplocepha species (1.5%), Strongvloides westeri (1.5%) and Strongyles + Ascaris (1.5%). The higher infection rate of helminth parasites were observed in spring (78%) and in summer (82%) as compare with autumn (40%) and winter (56%). Highest average EPG of 530 was recorded in summer and lowest EPG of 161 in winter season. Age related susceptibilities indicated a high prevalence of strongylosis in equines of under 10 years of age as compared with horses of more than 10 years of age. A higher egg per gram of the faeces were also recorded in horses of 1-3 years of age (512) as compared with older horses. Males have higher prevalence of helminths (76%) as compared with female (49%). There was no difference in average egg shedding by male (304) and fema1 horses (296). The anthelmintics efficacy of oxafax, ivomec and farbencja were also evaluated. Forty horses found positive for natural strongyle infection were randomly divided into four equal groups. Group A, B and C were dosed with Oxafax, Ivomec and Farbenda respectively as recommended by manufacturers. Group D acted as non-medicated infected control group. Percent egg reduction test indicated an efficacy of 96%, 98% and 81% for Oxafax, Ivomec and Farbenda, respectively on day 14 (post-medication). An efficacy of 100%, 96% and 86% were observed for Oxafax, Ivomec and Farbenda respectively on day 28, Statistically there was a non-significant difference in the efficacy of Oxafax, Ivomec and Farbendazole on days 14 and 28 post medication (P>O.05). However, these drugs showed a significant reduction in average EPG as compared with control group (P >0.05) on both sampling days ER -